Sort
39,280 grants matching “leukemia”
Chromosomal alterations in basic mechanisms of radiation injury
$369,160Susan M. Bailey · Colorado State University · R01 · FY2009 · AI
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma
$369,155Juan Carlos Ramos · University Of Miami School Of Medicine · R01 · FY2018 · CA
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
$369,126Michael A. Farrar · University Of Minnesota · R01 · FY2023 · CA
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
$369,126Michael A. Farrar · University Of Minnesota · R01 · FY2022 · CA
Molecular characterization of Acute Myeloid Leukemia
$369,114Irving Lerner Weissman · Stanford University · R01 · FY2006 · CA
DEREGULATION OF CELLULAR IKB KINASES BY HTLV1 TAX
$369,072Vanderbilt University · R01 · FY2001 · CA
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
$369,021Joaquin M. Espinosa · University Of Colorado Denver · R61 · FY2022 · HD
NEURON SURVIVAL IN CHAGAS DISEASE
$369,000Tufts University Boston · R01 · FY2001 · NS
Mechanisms of anemia of chronic inflammation and aging in mice.
$369,000Cindy Norene Roy · Johns Hopkins University · R01 · FY2009 · DK
NEURON SURVIVAL IN CHAGAS DISEASE
$369,000Tufts University Boston · R01 · FY2004 · NS
NEURON SURVIVAL IN CHAGAS DISEASE
$369,000Tufts University Boston · R01 · FY2003 · NS
NEURON SURVIVAL IN CHAGAS DISEASE
$369,000Tufts University Boston · R01 · FY2002 · NS
Control Mechanisms of Human Voltage Gated Proton Channels, hHv1
$368,950Thomas E Decoursey · Rush University Medical Center · R35 · FY2019 · GM
Control Mechanisms of Human Voltage Gated Proton Channels, hHv1
$368,950Thomas E Decoursey · Rush University Medical Center · R35 · FY2022 · GM
Control Mechanisms of Human Voltage Gated Proton Channels, hHv1
$368,950Thomas E Decoursey · Rush University Medical Center · R35 · FY2021 · GM
Control Mechanisms of Human Voltage Gated Proton Channels, hHv1
$368,950Thomas E Decoursey · Rush University Medical Center · R35 · FY2020 · GM
Targeting apoptosis via chemical design of Bcl-2 antagonists
$368,938Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA
REGULATION OF THE V MYB AND C MYB ONCOPROTEINS
$368,915University Of New Mexico · R01 · FY2003 · CA
Histologic and Molecular Characterization of Solid Pediatric Tumors
$368,901Maria Tsokos · Clinical Sciences · Z01 · FY2007 · CA
The role of leukemia inhibitory factor in colorectal cancer
$368,879Wenwei Hu · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Ionizing radiation induced hematological malignancies
$368,866Daohong Zhou · University Of Florida · R01 · FY2018 · CA
ALL therapy and developing brains: MRI measures, genetic factors and cognition
$368,817Wilburn E. Reddick · St. Jude Children'S Research Hospital · R01 · FY2014 · CA
Mitochondrial determination of response to targeted AML therapies
$368,813Anthony G Letai · Brigham And Women'S Hospital · P01 · FY2018 · CA
Mitochondrial determination of response to targeted AML therapies
$368,794Anthony G Letai · Brigham And Women'S Hospital · P01 · FY2017 · CA
Mitochondrial determination of response to targeted AML therapies
$368,774Anthony G Letai · Brigham And Women'S Hospital · P01 · FY2016 · CA